“The Molson” is a low-barrier, peer-staffed, supervised consumption site located in Vancouver, Canada. In addition to overdose response, this site offers drug checking and a colocated injectable hydromorphone treatment program, and it distributes tablet and liquid hydromorphone to service users at high risk of overdose. Our evaluation suggests benefits of this program in creating service continuums and preventing overdose deaths. From September 2017 to August 2019, the site had 128 944 visits, reversed 770 overdoses, and had no overdose deaths.


No related items


Downloaded 1,043 times



Michelle Olding, MPH, Andrew Ivsins, PhD, Samara Mayer, MPH, Alex Betsos, MSc, Jade Boyd, PhD, Christy Sutherland, MD, Coco Culbertson, Thomas Kerr, PhD, and Ryan McNeil, PhDMichelle Olding, Andrew Ivsins, Samara Mayer, Alex Betsos, Jade Boyd, and Thomas Kerr are with the BC Centre on Substance Use, Vancouver, Canada. Christy Sutherland and Coco Culbertson are with the Portland Hotel Society, Vancouver, Canada. Ryan McNeil is with the Yale University School of Medicine, New Haven, CT. “A Low-Barrier and Comprehensive Community-Based Harm-Reduction Site in Vancouver, Canada”, American Journal of Public Health 110, no. 6 (June 1, 2020): pp. 833-835.


PMID: 32298171